[Skip to Content]
[Skip to Content Landing]
Article
March 1982

Phosphate Therapy in Diabetic Ketoacidosis

Author Affiliations

From the Department of Medicine, Baylor College of Medicine, Houston.

Arch Intern Med. 1982;142(3):517-520. doi:10.1001/archinte.1982.00340160097021
Abstract

To determine the efficacy of phosphate replacement in the therapy for diabetic ketoacidosis (DKA), 44 patients were randomly assigned to three treatment groups: those who received no phosphate replacement, those who received 15 mmole of sodium phosphate at the fourth hour, or those who received 15 mmole of sodium phosphate at 2, 6, and 10 hours. All patients were treated with intravenous insulin injection (0.1 units/kg/hr), fluids, and potassium. Four hours after a 15-mmole sodium phosphate infusion, the serum phosphate level was 2.8 ± 0.8 mg/dl vs 2.1 ± 0.8 mg/dL in the control patients; however, this dose was insufficient to maintain the serum phosphate level at 16 and 24 hours. Forty-five millimoles of phosphate prevented severe hypophosphatemia in all but one patient and produced substantially higher phosphate levels at 8, 16, and 24 hours. Phosphate therapy did not affect the duration of DKA, dose of insulin required to correct the acidosis, abnormal muscle enzyme levels, glucose disappearance, or morbidity and mortality. Although theoretically appealing, phosphate therapy is not an essential part of the therapy for DKA in most patients.

(Arch Intern Med 1982;142:517-520)

References
1.
Knochel JP:  The pathophysiology and clinical characteristics of severe hypophosphatemia.  Arch Intern Med 1977;137:203-220.Crossref
2.
Kreisberg RA:  Phosphorus deficiency and hypophosphatemia.  Hosp Pract , (March) 1977, pp 121-128.
3.
Kreisberg RA:  Diabetic ketoacidosis: New concepts and trends in pathogenesis and treatment.  Ann Intern Med 1978;88:681-695.Crossref
4.
Fitzgerald F:  Clinical hypophosphatemia.  Annu Rev Med 1978;29:177-189.Crossref
5.
Guest GM, Rapoport S:  Electrolytes of blood plasma and cells in diabetic acidosis and during recovery.  Proc Am Diabetes Assoc 1947;7:95-115.
6.
Franks M, Berris RF, Kaplan NO, et al:  Metabolic studies in diabetic acidosis: II. The effect of the administration of sodium phosphate.  Arch Intern Med 1948;81:42-55.Crossref
7.
Jacob HS, Amsden T:  Acute hemolytic anemia with rigid red cells in hypophosphatemia.  N Engl J Med 1971;285:1446-1450.Crossref
8.
Knochel JP, Bilbrey GL, Fuller TJ, et al:  The muscle cell in chronic alcoholism: The possible role of phosphate depletion in alcoholic myopathy.  Ann NY Acad Sci 1976;252:274-286.Crossref
9.
O'Connor LR, Wheeler WS, Bethume JE:  Effect of hypophosphatemia on myocardial performance in man.  N Engl J Med 1977;297:901-903.Crossref
10.
Darsee JR, Nutter DO:  Reversible severe congestive cardiomyopathy in three cases of hypophosphatemia.  Ann Intern Med 1978;89:867-870.Crossref
11.
Alberti KGMM, Emerson PM, Darley JR, et al:  2,3-Diphosphoglycerate and tissue oxygenation in uncontrolled diabetes mellitus.  Lancet 1972;2:391-395.Crossref
12.
Holler JW:  Potassium deficiency occurring during treatment of diabetic acidosis.  JAMA 1946;131:1186-1189.Crossref
13.
Kunin AS, Surawiez B, Eims EAH:  Decrease in serum potassium concentration and appearance of cardiac arrhythmias during infusion of potassium with glucose in potassium depleted patients.  N Engl J Med 1962;266:228-233.Crossref
14.
Clements RS, Vourganti B:  Fatal diabetic ketoacidosis: Major causes and approaches to their prevention.  Diabetes Care 1978;1:314-325.
15.
Levine SN, Loewenstein JE:  Treatment of diabetic ketoacidosis.  Arch Intern Med 1981;141:713-715.Crossref
16.
DeFronzo RA, Lang R:  Hypophosphatemia and glucose tolerance: Evidence for tissue insensitivity to insulin.  N Engl J Med 1980;303:1259-1263.Crossref
17.
Keller U, Berger W:  Prevention of hypophosphatemia by phosphate infusion during treatment of diabetic ketoacidosis and hyperosmolar coma.  Diabetes 1980;29:87-95.Crossref
18.
Knight AH, Williams DN, Spooner RJ, et al:  Serum enzyme changes in diabetic ketoacidosis.  Diabetes 1974;23:126-131.
19.
VéLez-Garcia E, Hardy P, Dioso M, et al:  Cysteine-stimulated serum creatine-phosphokinase: Unexpected results.  J Lab Clin Med 1966;68:636-645.
20.
Patak RV, Fadem SZ, Lifschitz MD, et al:  Study of factors which modify the development of norepinephrine-induced acute renal failure in the dog.  Kidney Int 1979;15:227-237.Crossref
21.
Shackney S, Hasson J:  Precipitous fall in serum calcium, hypotension and acute renal failure after intravenous phosphate therapy for hypercalcemia.  Ann Intern Med 1967;66:906-916.Crossref
22.
Winters RJ, Harris CJ, Phillips LS, et al:  Diabetic ketoacidosis: Induction of hypocalcemia and hypomagnesemia by phosphate therapy.  Am J Med 1979;67:897.Crossref
23.
Lavis VR:  Treatment of diabetic ketoacidosis.  Diabetes Care 1979;2:385-386.
24.
Newman JH, Neff TA, Ziparin P:  Acute respiratory failure associated with hypophosphatemia.  N Engl J Med 1977;296:1101-1103.Crossref
25.
Craddock PR, Yawata Y, Van Santen L, et al:  Acquired phagocyte dysfunction: A complication of the hypophosphatemia of parenteral hyperalimentation.  N Engl J Med 1974;290:1403-1407.Crossref
×